Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

ATRA

  • Open Access
    Resveratrol Can Differentiate Human Melanoma Stem-like Cells from Spheroids Treated With All-trans Retinoic Acid
    MINA KANAI, AKIHO SHINAGAWA, MASAKO OTA, NANTIGA VIRGONA and TOMOHIRO YANO
    Anticancer Research December 2024, 44 (12) 5283-5292; DOI: https://doi.org/10.21873/anticanres.17356
  • You have access
    All-trans Retinoic Acid Overcomes Acquired Resistance to PLX4032 via Inhibition of PIN1 in Melanoma Cells
    GARAM KIM, POSHAN YUGAL BHATTARAI, CHANG-HYUN OH and HONG SEOK CHOI
    Anticancer Research December 2019, 39 (12) 6537-6546; DOI: https://doi.org/10.21873/anticanres.13869
  • You have access
    Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells
    ANNEKATHRIN REINHARDT, HONGYU LIU, YUNXIA MA, YONGAN ZHOU, CHUANBING ZANG, JAN-PIET HABBEL, KURT POSSINGER and JAN EUCKER
    Anticancer Research May 2018, 38 (5) 2669-2682;
  • You have access
    Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma Xenografts
    THOMAS SCHMOCH, ZOLTAN GAL, ANDREAS MOCK, JAN MOSSEMANN, BERND LAHRMANN, NIELS GRABE, PETER SCHMEZER, FELIX LASITSCHKA, PHILIPP BECKHOVE, ANDREAS UNTERBERG and CHRISTEL HEROLD-MENDE
    Anticancer Research April 2016, 36 (4) 1489-1496;
  • You have access
    Treatment of Acute Promyelocytic Leukemia
    EHAB ELBAHESH, NIHAR PATEL and IMAD A. TABBARA
    Anticancer Research April 2014, 34 (4) 1507-1517;
  • You have access
    DNA Methylation in ATRA-treated Leukemia Cell Lines Lacking a PML–RAR Chromosome Translocation
    REGINA MIFTAKHOVA, TOVE SANDBERG, ANDREAS HEDBLOM, TATYANA NEVZOROVA, JENNY L. PERSSON and ANDERS BREDBERG
    Anticancer Research November 2012, 32 (11) 4715-4722;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire